SynergyFinder™ and NFK GreenScreen™ presented at EORTC-NCI-AACR conference in Barcelona
Guido Zaman, Joost Uitdehaag and Suzanne van Gerwen will attend the 26th EORTC-NCI-AACR symposium on “Molecular Targets and Cancer Therapeutics”, that will be held in Barcelona from November 18th to 21st.

On Tuesday, November 19th, a poster will be presented on the application of NFK Green™ for high-throughput screening and the new NFK GreenScreen™ assay for mouse IDO1 that was recently developed.
Title: Identification of inhibitors of tryptophan metabolizing enzymes for cancer immunotherapy by high-throughput screening
Session: Drug Screening.
Abstract number: 104. Poster board: 098.

On Wednesday, November 20th, a poster will be presented on the application of SynergyFinder™ to identify new drug combinations that target specifically certain cancer driver genes hat are difficult to drug with small molecules.
Title: Synergistic drug combinations that target β-catenin-driven and MYC-driven cancers
Session: Molecular Targeted Agents 1. Abstract number: 349. Poster board: 129.